	From Tumour to Bloodstream: Advancing PD-L1 Testing With Liquid Biopsies in Non-Small Cell Lung Cancer. Cytopathology Leporati R, Callegari V, Ancora A, Palmieri M, Riccò B, Cabitza E, Trudu L, Di Emidio K, Chiavelli C, Eccher A, Mastrolia I, Catani V, Bettelli S, Guaitoli G, Dominici M, Bertolini F. PMID: 42218596 [PubMed - as supplied by publisher]
	Smoking-Related Comorbidities Detected Through Low-dose CT Lung Cancer Screening: Current Evidence and Future Directions. Chest Revel MP, Goo JM, Vliegenthart R, Silva M, Snoeckx A. PMID: 42217822 [PubMed - as supplied by publisher]
	Lorlatinib versus crizotinib as first-line treatment for advanced ALK-positive non-small cell lung cancer: 7-year update from the phase 3 CROWN study. Ann Oncol Shaw AT, Solomon BJ, Felip E, Bauer TM, Liu G, Goto Y, Wu YL, Soo RA, Mazieres J, Kim DW, Wang IM, Paolini J, Polli A, Rifi N, Toffalorio F, Mok TSK. PMID: 42217582 [PubMed - as supplied by publisher]
	Design, synthesis, and mechanistic study of novel isoflavone derivatives as mitochondrial complex I inhibitors for non-small cell lung cancer treatment. Bioorg Chem Liu J, Meng N, Li R, Liu M, Ma Y, Liu X, Chen J, Cheng Y. PMID: 42217500 [PubMed - as supplied by publisher]
	Circulating tumor DNA analysis in lung cancer: from molecular origins to analytical boundaries. Lung Cancer Zhang JT, Lin BX, Zhao XG, Zhong WZ, Wu YL. PMID: 42217421 [PubMed - as supplied by publisher]
	Aristolochic acid and the risk of female lung cancer: Population-based case-control study in Taiwan. Cancer Epidemiol Chen CJ, Yang YH, Chiang XH, Lin CC, Lu TP, Chen JS, Chen PC. PMID: 42217389 [PubMed - as supplied by publisher]
	E-cigarettes for tobacco harm reduction in older adults who fail tobacco cessation treatment offered at lung cancer screening: a pilot trial. Nicotine Tob Res Avila JC, Erinoso O, Tripathi N, Boateng J, Triehy C, Marotta C, McCann C, Reyen M, Regan S, Haas JS, Park ER, Rigotti NA. PMID: 42217177 [PubMed - as supplied by publisher]
	Hounsfield Unit Dynamics During CT-Guided Transthoracic Core Needle Biopsy as a Predictor of Malignant vs. Non-Malignant Thoracic Lesions. Br J Hosp Med (Lond) Ye, Kerget B, Küçüko, Ayd, Aksakal A, Karaman A, Alper F. PMID: 42216597 [PubMed - indexed for MEDLINE]
	First-line envafolimab plus recombinant human-endostatin inÂ advanced non-small cell lung cancer with PD-L1 tumor proportion score â‰¥1% (Endouble): A multicenter, prospective, single-arm, phase 2 trial. Cancer Dong C, Liu L, Qiao Y, Wang M, Song D, Zhou L, Ji Y, Li Y, Ding F, Wang H, Zhuang M, Wang L, Liu Z, Fei H, Guo X, Bian B, Yuan C, Xu G, Fang L, Li Y, Song Z, Hui K, Jiang X. PMID: 42216493 [PubMed - indexed for MEDLINE]
	Amivantamab in advanced non-small cell lung cancer with epidermal growth factor receptor exon 20 insertion mutations: Real-world data from the Italian ATLAS Registry. Cancer Passiglia F, Passaro A, Gariazzo E, Montrone M, Pasello G, Tiseo M, Russano M, Citarella F, Muscarella LA, Pozzessere D, Bria E, Roca E, Cerea G, Russo A, Grisanti S, Bulotta A, Veccia A, Biello F, Lo Russo G, Pilotto S, Genova C, Cortinovis D, Minuti G, Meoni G, Gori S, Reale ML, Pavan A, Ramundo M, Grossi F, Parra HS, Scotti V, Vavalà T, Sini C, Sergi C, Pelizzari G, Chiari R, Stanzione B, Favaretto A, Leone F, Bettini AC, Pagano M, Tondulli L, Toschi L, Lacidogna G, Bennati C, Catanese S, Malapelle U, Giannarelli D, Novello S. PMID: 42216441 [PubMed - indexed for MEDLINE]
	Predictive value of the prothrombin time-to-albumin ratio for 28- and 90-day mortality in lung cancer patients admitted to the intensive care unit: A retrospective cohort study. Medicine (Baltimore) Jia F, Xia G, Xu T, Hu L, Wu S, Liu L, Lei X. PMID: 42216324 [PubMed - indexed for MEDLINE]
	Safety, pharmacokinetics, pharmacodynamics and antitumor activity of legubicin in patients with advanced solid tumors, including lung cancer: a phase 1 dose-escalation and expansion trial. BMC Cancer Lin F, Xue J, Li Q, Tang W, Zhao W, Xue L, Zhou J, Liu Y, Jin W, Sun H, Liu C, Guo Y, Li J. PMID: 42215940 [PubMed - as supplied by publisher]
	Effects of different telehabilitation methods on postoperative pulmonary rehabilitation of patients with lung cancer: a systematic review and network meta-analysis of randomised controlled trials protocol. BMJ Open Liu J, Niu H, Li J, Chen Q, Bi H. PMID: 42215264 [PubMed - indexed for MEDLINE]
	Integration of habitat radiomics and 2.5D deep features from (18)F-FDG PET/CT for noninvasive prediction of PD-L1 TPSÂ â‰¥Â 50% in non-small cell lung cancer. Eur J Radiol Yang F, Wang D, Wang D, Wang H, Li X, Zhao Y, Shi L, Cai Y, Ke S, Li P. PMID: 42214904 [PubMed - as supplied by publisher]
	Metabolic-epigenetic crosstalk in lung cancer: Glycolytic reprogramming and lactylation-driven macrophage polarization. Pathol Res Pract Wang C, Liu S, Fan J, Liu L, Sun Y. PMID: 42214873 [PubMed - as supplied by publisher]
	Sacituzumab tirumotecan plus pembrolizumab versus pembrolizumab in PD-L1-positive advanced non-small-cell lung cancer (OptiTROP-Lung05): interim analysis of a randomised, open-label, phase 3 trial. Lancet Xiong A, Yao W, Zheng W, Yu Y, Chen P, Zhong H, Ge J, Wang H, Chen B, Wang H, Fan Y, Yang Y, Pu X, Song X, Wang Q, Du X, Huang Z, Li X, Luo H, Yao Y, Yu Q, Su C, He L, Jiang G, Cui J, Liu C, Yi T, Che G, Liu Z, Zhang L, Zhou M, Fang Y, Wei Y, Qing Y, Jin X, Zhou C. PMID: 42214392 [PubMed - as supplied by publisher]
	Impact of Immune Checkpoint Inhibitor-Combined Chemotherapy as First-Line Treatment for Non-Small Cell Lung Cancer With Brain Metastases. Clin Lung Cancer Aliouat A, Chareire A, Bodergat T, Moncharmont C, Pierre C, Geier M, Lasvergnas J, Zysman M, Pinsolle J, Guibert C, Perrot E, Tekhneriadov A, Pons-Tostivint E, Toffart AC. PMID: 42214267 [PubMed - as supplied by publisher]
	Efficacy and safety of subcutaneous and intravenous administration of atezolizumab in patients with non-small cell lung cancer, including early-stage, locally advanced or metastatic disease: Updated results of the IMscin001 and IMscin002 randomized studies. Lung Cancer Burotto M, Zvirbule Z, Alvarez R, Chewaskulyong B, Felip E, Majem M, Korbenfeld E, Kolb-Sielecki J, Isla D, Barata T, Bustillos A, Herraez-Baranda LA, Tosti N, Young F, Zanghi J, Cappuzzo F. PMID: 42214243 [PubMed - as supplied by publisher]
	Prevalence of PD-L1 Expression in Non-Small Cell Lung Cancer: A Real-World Analysis From Jordan. JCO Glob Oncol El Khatib O, Obeidat N, Yaseen A, Khader R, Al-Yagoub M, Haroon N, Zayed A, Ghlailat M, Hamadneh Y, Al-Showbaki L, Haddad H, Yaser S, Mahmoud N, Abdel Jalil R, Al-Batsh T, Abdel Rahman Z, Shahin O, Ma'koseh M, Halahleh K, Al-Ibraheem A, Al-Jaghbeer MJ, Aljadayeh MH, Al Maani J, Tamimi F, Al-Rabi K. PMID: 42214046 [PubMed - indexed for MEDLINE]
	The association and risk prediction of the ubiquitination pathway genetic variants and lung cancer incidence: A nested case-control study. Cancer Epidemiol Biomarkers Prev Mao J, Leng L, Zhu T, Wang J, Zhao G, Liu X, Liu H, Wu Y, Cheng L, Zhang R. PMID: 42213488 [PubMed - as supplied by publisher]

Articles 1 - 20 / 159136

Page 1 of 7957



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy